Analyst Ratings for Jazz Pharmaceuticals (JAZZ) [Neutrals]
JAZZ Rating Summary
JAZZ Price Target Summary
- Highest: $230.00 (Barclays)
- Lowest: $131.00 (UBS)
- Average: $184.58
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$184.58 (+71.8%)
* Over Last 12-Mos
Rating Score: 8.4 / 10
Percentile Rank: 87%
Avg. $ Target:
$184.58 (+71.8%)
* Over Last 12-Mos
Rating Score: 8.4 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/27/2023 | UBS » Updated 3/1/2024 |
Ashwani Verma | Downgrade | Neutral (Buy) |
131.00 (135.00) |
121.72 (107.43) |
-11.74% | Details |
| 9/29/2023 | Raymond James | N/A | New Coverage | Market Perform (N/A) |
N/A (N/A) |
131.23 (107.43) |
-18.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
